These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31187327)

  • 1. Foregone Inclusion: Neonatal CMV Hepatitis and Cholestasis.
    Martin M; Holmes S; Sim J; Hassan M; Mathew R; Bensen R; Barakat M
    Dig Dis Sci; 2019 Nov; 64(11):3092-3095. PubMed ID: 31187327
    [No Abstract]   [Full Text] [Related]  

  • 2. Case Report of a Rare Presentation of Isolated Cytomegalovirus Hepatitis After Renal Transplantation.
    Soape MP; Rahimi RS; Spak CW; Trotter JF
    Prog Transplant; 2018 Sep; 28(3):296-298. PubMed ID: 29898621
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholestasis caused by panhypopituitarism and acquired cytomegalovirus infection in a 2-month-old male infant: A case report.
    Chan U; Chan WT; Ting WH; Ho CS; Liu HC; Lee HC
    Medicine (Baltimore); 2017 Apr; 96(17):e6757. PubMed ID: 28445302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis.
    Fischler B; Casswall TH; Malmborg P; Nemeth A
    J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):154-7. PubMed ID: 11840032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Valganciclovir Use Among Infants with Congenital Cytomegalovirus Diagnosis in the United States, 2009-2015 and 2016-2019.
    Leung J; Grosse SD; Hong K; Pesch MH; Lanzieri TM
    J Pediatr; 2022 Jul; 246():274-278.e2. PubMed ID: 35358586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: ganciclovir treatment in infants with cytomegalovirus infection and cholestasis.
    Jonas MM
    J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):399-400; author reply 400. PubMed ID: 12352538
    [No Abstract]   [Full Text] [Related]  

  • 7. Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.
    Maertens J; Cordonnier C; Jaksch P; Poiré X; Uknis M; Wu J; Wijatyk A; Saliba F; Witzke O; Villano S
    N Engl J Med; 2019 Sep; 381(12):1136-1147. PubMed ID: 31532960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the therapeutic approach to congenital cytomegalovirus infection.
    Garrido-Barbero M; Arnaez J; Garcia-Alix A
    Infection; 2020 Jun; 48(3):463-469. PubMed ID: 32125680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection.
    Buonuomo PS; Maurizi P; Valentini P; Mastrangelo S; Lazzareschi I; Ridola V; Riccardi R
    J Perinatol; 2006 Oct; 26(10):648-9. PubMed ID: 17006527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valganciclovir treatment of neonatal cytomegalovirus induced hepatitis].
    Quero JC; Parras AP; Garrido AA; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Oct; 71(4):367-8. PubMed ID: 19729354
    [No Abstract]   [Full Text] [Related]  

  • 11. Valganciclovir therapy for a neonate with congenital cytomegalovirus pneumonitis.
    Kanda R; Shimizu D; Hoshina T; Ogawa M; Kusuhara K
    Pediatr Int; 2021 Dec; 63(12):1526-1528. PubMed ID: 34399019
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study.
    Bartlett AW; Hall BM; Palasanthiran P; McMullan B; Shand AW; Rawlinson WD
    J Clin Virol; 2018 Nov; 108():121-125. PubMed ID: 30300787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey of valganciclovir dosing strategies in pediatric organ transplant recipients.
    Shaikh S; Jasiak-Panek N; Park JM
    Clin Transplant; 2018 Sep; 32(9):e13369. PubMed ID: 30076649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss.
    Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E
    J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-year follow-up of congenital cytomegalovirus infection complicated with severe neurological findings in infancy: a case report.
    Suganuma E; Oka A; Sakata H; Adachi N; Asanuma S; Oguma E; Yamaguchi A; Furuichi M; Uejima Y; Sato S; Takano T; Kawano Y; Tanaka R; Arai T; Oh-Ishi T
    BMC Pediatr; 2018 Nov; 18(1):369. PubMed ID: 30470211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report.
    Agarwal SK; Kalra V; Dinda A; Gupta S; Dash SC; Bhowmik D; Tiwari SC
    Int Urol Nephrol; 2004; 36(3):433-5. PubMed ID: 15783120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis.
    Ozkan TB; Mistik R; Dikici B; Nazlioglu HO
    BMC Gastroenterol; 2007 Mar; 7():9. PubMed ID: 17355631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary atresia and cytomegalovirus and response to valganciclovir.
    Shah I; Bhatnagar S
    Indian Pediatr; 2012 Jun; 49(6):484-6. PubMed ID: 22796690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus viremia in lung transplantation during and after prophylaxis.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13069. PubMed ID: 30884067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus primoinfection in inflammatory bowel disease.
    Torres P; Lobatón T; Cañete F; Clos A; Mañosa M; Cabré E; Domènech E
    Gastroenterol Hepatol; 2018; 41(7):453-454. PubMed ID: 28734481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.